Tag: Vertess
In brief: Hurricane waivers, NIV advocacy, CRT lobby
October 4, 2024HME News Staff
WASHINGTON – CMS will permit people with Medicare who have lost or had damage to their DMEPOS products because of Hurricane Helene to receive replacements of such items and services, according to a bulletin from AAHomecare.
Specifically, CMS waivers for Florida, Georgia, North Carolina, South Carolina, and Tennessee state that:
When DMEPOS is lost, destroyed, irreparably damaged, or otherwise rendered unusable, CMS is allowing DME MACs to have the flexibility to waive...
Vertess taps health care exec as new managing director
October 3, 2024HME News Staff
FORT WORTH, Texas – Vertess has added senior health care executive Christine M. Bartel to the team as managing director. Bartel has nearly 30 years of health care experience in administration and executive leadership positions responsible for clinical compliance, care coordination and operational efficiencies, including financial integrity and growth strategies. She started Hope at Home, Inc. and Aspire Home Care, a private duty agency and skilled home care agency, respectively, in Colorado....
In brief: CCS launches PropheSee, Vertess’ Smith recognized
June 12, 2024HME News Staff
DALLAS – CCS has launched PropheSee, an AI-powered predictive model for health care organizations focused on improving adherence in people with diabetes who use a continuous glucose monitoring (CGM) device.
With the deployment of this new predictive model, CCS has observed increases in adherence rates among targeted, high-risk patient cohorts by as much as 50% compared to control groups. The increase in adherence resulted from tech-enabled, personalized interventions based on risk...
Vertess partner recognized for deal
June 10, 2024HME News Staff
FORT WORTH, Texas – Vertess has announced that Bradley Smith, managing director/partner, has been recognized as an M&A advisor for one of Axial’s Top 8 Deals of 2023. Axial, a private deal network serving professionals who own, advise and invest in North American companies, named Smith’s deal a top transaction across the health care industry last year. He provided sell side representation for a medical device manufacturer in a transaction that took 12 months from signing to closing...
In brief: SoCal’s new ‘powerful platform,’ Vertess’ recognition, WHILL’s growth
May 10, 2024HME News Staff
TUSTIN, Calif. – SG Homecare, a provider of HME and supplies, has acquired Western Drug Medical Supply, creating a platform to scale in Southern California.
The combined entity has more than $150 million in annual revenue and more than 500 employees.
"This is a transformative moment for both SG Homecare and Western Drug Medical Supply," said Jay Wendt, CEO, SG Homecare. "We're committed to a seamless integration, fostering a powerful platform for growth....
Vertess recognized for dealmaking
May 9, 2024HME News Staff
FORT WORTH, Texas – Vertess was recently named the No. 1 lower middle market investment bank for Q1 2024 by Axial, a private deal network serving professionals who own, advise and invest in North American companies. Vertess facilitated three transactions in the quarter:
MyDoc Urgent Care, a multi-location urgent care center based in Pennsylvania, was acquired by MyTown Health Partners, a comprehensive practice management services organization recently formed by Webster Equity...
In brief: Vivos picks Lincare, industry wins in GA, Belluscura tries DTC
October 27, 2023HME News Staff
LITTLETON, Colo. – Vivos Therapeutics, a medical technology company that makes oral appliances for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, has signed a distribution agreement with Lincare.
The agreement follows a successful a distribution pilot with Lincare and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment companies in the United States. Lincare will have a six-month exclusive deal...
Vertess announces pick up in M&A activity
October 26, 2023HME News Staff
FORTH WORTH, Texas – Vertess has closed five major health care transactions in the third quarter of 2023 with a total value of $75 million. The transactions were in various health care verticals. "At the end of 2022 and early 2023, we saw a sharp decline in the pace of M&A activity,” said Brad Smith, managing director. “We continued to push forward and remain patient. We are pleased for our clients that our perseverance with buyers resulted in several successes." Vertess sees signs...
M&A: Get your stories straight
March 29, 2023Theresa Flaherty, Managing Editor
DALLAS – While uncertainty in the broader economy has caused a slowdown in M&A, when buyers and sellers know what they want, deals are getting done, said experts at Medtrade on Tuesday.
“Why do you want to transact?” asked Brad Smith, managing director/partner at Vertess. “Why do you want to buy or sell? (If you’re selling), give a buyer enough information so they can make an educated decision. Make it a conversation. Have calls; get to know these people.”
Smith...
M&A analysts: ‘Focus on acquiring solid companies’
February 10, 2023Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Industry analysts see steady deal-making in 2023, with a variety of companies making buys in both typically hot markets like respiratory and newly hot markets like repairs, but with more of a focus on due diligence.
“I think the interest is at both the national level, as well as the larger regionals, aggressively pursuing acquisitions,” said Pat Clifford, managing director, home medical equipment, for The Braff Group. “There is acquisition appetite...